In their study, it has been observed that in the guts of patients with T2D, naively treated with metformin for three days, B. fragilis decreased, while GUDCA increased, with an inhibition of FXR signaling and an improvement of various metabolic endpoint dysfunctions, including hyperglycemia. Here, NR1H4 is linked to Hyperglycemia.